Cargando…

Simultaneous micronization and purification of bioactive fraction by supercritical antisolvent technology

Simultaneous micronization and purification of DLBS3233 bioactive fraction, a combination of two Indonesian herbals Lagerstroemia speciosa and Cinnamomum burmannii has been successfully performed via supercritical anti-solvent (SAS) technology. The objective of the present study was to investigate t...

Descripción completa

Detalles Bibliográficos
Autores principales: Hiendrawan, Stevanus, Veriansyah, Bambang, Widjojokusumo, Edward, Tjandrawinata, Raymond R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5416655/
https://www.ncbi.nlm.nih.gov/pubmed/28516056
http://dx.doi.org/10.4103/japtr.JAPTR_164_16
_version_ 1783233790460559360
author Hiendrawan, Stevanus
Veriansyah, Bambang
Widjojokusumo, Edward
Tjandrawinata, Raymond R.
author_facet Hiendrawan, Stevanus
Veriansyah, Bambang
Widjojokusumo, Edward
Tjandrawinata, Raymond R.
author_sort Hiendrawan, Stevanus
collection PubMed
description Simultaneous micronization and purification of DLBS3233 bioactive fraction, a combination of two Indonesian herbals Lagerstroemia speciosa and Cinnamomum burmannii has been successfully performed via supercritical anti-solvent (SAS) technology. The objective of the present study was to investigate the effectiveness of SAS technology to micronize and reduce coumarin content of DLBS3233. The effects of four SAS process parameters, i.e. pressure, temperature, concentration and solution flow rate on particle formation were investigated. In SAS process, DLBS3233 was dissolved in dimethylformamide (DMF) as the liquid solvent. The solution was then pumped through a nozzle into a chamber simultaneously with supercritical carbon dioxide (SC-CO2) which acts as the anti-solvent, resulting in DLBS3233 precipitation. Physicochemical properties of unprocessed DLBS3233 and SAS-processed DLBS3233 particles were analyzed using scanning electron microscopy (SEM) and high pressure liquid chromatography (HPLC). Total polyphenol content (TPC) was also analyzed. Particles with mean particle size ranging from 0.107±0.028 μm to 0.298±0.138 μm were obtained by varying the process parameters. SAS-processed DLBS3233 particles showed no coumarin content in all experiments studied in this work. Results of TPC analysis revealed no significant change in SAS-processed DLBS3233 particles compared to unprocessed DLBS3233. Nano-sized DLBS3233 particles with no coumarin content have been successfully produced using SAS process. This study demonstrates the ability of SAS for processing herbal medicine in single step process.
format Online
Article
Text
id pubmed-5416655
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-54166552017-05-17 Simultaneous micronization and purification of bioactive fraction by supercritical antisolvent technology Hiendrawan, Stevanus Veriansyah, Bambang Widjojokusumo, Edward Tjandrawinata, Raymond R. J Adv Pharm Technol Res Original Article Simultaneous micronization and purification of DLBS3233 bioactive fraction, a combination of two Indonesian herbals Lagerstroemia speciosa and Cinnamomum burmannii has been successfully performed via supercritical anti-solvent (SAS) technology. The objective of the present study was to investigate the effectiveness of SAS technology to micronize and reduce coumarin content of DLBS3233. The effects of four SAS process parameters, i.e. pressure, temperature, concentration and solution flow rate on particle formation were investigated. In SAS process, DLBS3233 was dissolved in dimethylformamide (DMF) as the liquid solvent. The solution was then pumped through a nozzle into a chamber simultaneously with supercritical carbon dioxide (SC-CO2) which acts as the anti-solvent, resulting in DLBS3233 precipitation. Physicochemical properties of unprocessed DLBS3233 and SAS-processed DLBS3233 particles were analyzed using scanning electron microscopy (SEM) and high pressure liquid chromatography (HPLC). Total polyphenol content (TPC) was also analyzed. Particles with mean particle size ranging from 0.107±0.028 μm to 0.298±0.138 μm were obtained by varying the process parameters. SAS-processed DLBS3233 particles showed no coumarin content in all experiments studied in this work. Results of TPC analysis revealed no significant change in SAS-processed DLBS3233 particles compared to unprocessed DLBS3233. Nano-sized DLBS3233 particles with no coumarin content have been successfully produced using SAS process. This study demonstrates the ability of SAS for processing herbal medicine in single step process. Medknow Publications & Media Pvt Ltd 2017 /pmc/articles/PMC5416655/ /pubmed/28516056 http://dx.doi.org/10.4103/japtr.JAPTR_164_16 Text en Copyright: © 2017 Journal of Advanced Pharmaceutical Technology & Research http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Original Article
Hiendrawan, Stevanus
Veriansyah, Bambang
Widjojokusumo, Edward
Tjandrawinata, Raymond R.
Simultaneous micronization and purification of bioactive fraction by supercritical antisolvent technology
title Simultaneous micronization and purification of bioactive fraction by supercritical antisolvent technology
title_full Simultaneous micronization and purification of bioactive fraction by supercritical antisolvent technology
title_fullStr Simultaneous micronization and purification of bioactive fraction by supercritical antisolvent technology
title_full_unstemmed Simultaneous micronization and purification of bioactive fraction by supercritical antisolvent technology
title_short Simultaneous micronization and purification of bioactive fraction by supercritical antisolvent technology
title_sort simultaneous micronization and purification of bioactive fraction by supercritical antisolvent technology
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5416655/
https://www.ncbi.nlm.nih.gov/pubmed/28516056
http://dx.doi.org/10.4103/japtr.JAPTR_164_16
work_keys_str_mv AT hiendrawanstevanus simultaneousmicronizationandpurificationofbioactivefractionbysupercriticalantisolventtechnology
AT veriansyahbambang simultaneousmicronizationandpurificationofbioactivefractionbysupercriticalantisolventtechnology
AT widjojokusumoedward simultaneousmicronizationandpurificationofbioactivefractionbysupercriticalantisolventtechnology
AT tjandrawinataraymondr simultaneousmicronizationandpurificationofbioactivefractionbysupercriticalantisolventtechnology